Publications by authors named "Andreas Behren"

Claim this Profile
A
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity.
Tirta M Djajawi, Anne Huber, Sarahi Mendoza Rivera, Akash Srivaths, Maede Salehi, Andreas Behren

Cell Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer.
Camilla M Reehorst, Jennifer K Mooi, Charles J Uy, Kristen A Needham, Sarah Ellis, Andreas Behren

Clin Exp Metastasis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer biobanking in Australia: challenges and future directions.
Sarah Yeo, Stephen Q Wong, Farzaneh Atashrazm, Andreas Behren, Anthony T Papenfuss

Med J Aust· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
Megan B Barnet, Katherine J L Jackson, Etienne Masle-Farquhar, Amanda Russell, Deborah L Burnett, Andreas Behren

Proc Natl Acad Sci U S A· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient.
Tegan Ormston, Jessica Da Gama Duarte, Luke T Quigley, Louise Jackett, John Whitlam, Andreas Behren

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell factor 1 (TCF-1) defines T cell differentiation in colorectal cancer.
Kelly Tran, Anita N Kumari, Dinesh Raghu, Daniel R A Cox, Su Kah Goh, Andreas Behren

iScience· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers.
Thomas S Fulford, Caroline Soliman, Rebecca G Castle, Marc Rigau, Zheng Ruan, Andreas Behren

Nat Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity.
Tirta M Djajawi, Lizzy Pijpers, Akash Srivaths, David Chisanga, Kok Fei Chan, Andreas Behren

Cell Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gut microbial signature for combination immune checkpoint blockade across cancer types.
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Andreas Behren

Nat Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable response to combination immunotherapy using nivolumab and ipilimumab in metastatic succinate dehydrogenase (SDH)-deficient gastrointestinal stroma tumour.
Oliver Klein, Jodie Palmer, Andreas Behren, Jonathan Cebon, Damien Kee

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma.
Marina H Yakou, Sonia Ghilas, Kelly Tran, Yang Liao, Shoukat Afshar-Sterle, Andreas Behren

Sci Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?
Oliver Klein, Damien Kee, Adnan Nagrial, Ben Markman, Craig Underhill, Andreas Behren

Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opalâ„¢-TSA multiplex immunohistochemistry.
Luke T Quigley, Lokman Pang, Elnaz Tavancheh, Matthias Ernst, Andreas Behren

STAR Protoc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SERS Multiplex Profiling of Melanoma Circulating Tumor Cells for Predicting the Response to Immune Checkpoint Blockade Therapy.
Junrong Li, Alain Wuethrich, Zhen Zhang, Jing Wang, Lynlee L Lin, Andreas Behren

Anal Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Know thyself' - host factors influencing cancer response to immune checkpoint inhibitors.
Ashray Gunjur, Andrea J Manrique-Rincón, Oliver Klein, Andreas Behren, Trevor D Lawley

J Pathol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.
Kok Fei Chan, Jessica Da Gama Duarte, Simone Ostrouska, Andreas Behren

Front Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial.
Oliver Klein, Damien Kee, Bo Gao, Ben Markman, Jessica da Gama Duarte, Andreas Behren

J Immunother Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.
Sagun Parakh, Ashan Musafer, Sabrina Paessler, Tom Witkowski, Connie S N Li Wai Suen, Andreas Behren

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies.
Jessica Da Gama Duarte, Luke T Quigley, Anna Rachel Young, Masaru Hayashi, Mariko Miyazawa, Andreas Behren

Int J Mol Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting butyrophilins for cancer immunotherapy.
Marc Rigau, Adam P Uldrich, Andreas Behren

Trends Immunol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
Nicolas Jacquelot, Cyril Seillet, Minyu Wang, Angela Pizzolla, Yang Liao, Andreas Behren

Nat Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Single Cell Proteomics Reveals Circulating Tumor Cell Heterogeneity during Treatment.
K Kamil Reza, Shuvashis Dey, Alain Wuethrich, Jing Wang, Andreas Behren

ACS Nano· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy.
Oliver Klein, Damien Kee, Ben Markman, Matteo S Carlino, Craig Underhill, Andreas Behren

Cancer Cell· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538.
Oliver Klein, Clare Senko, Matteo S Carlino, Ben Markman, Louise Jackett, Andreas Behren

Oncoimmunology· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses.
Jessica Da Gama Duarte, Katherine Woods, Luke T Quigley, Cyril Deceneux, Candani Tutuka, Andreas Behren

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis